AB
Andrew Brennan
Venture CapitalActiveInvestment Analyst at Accolade Partners
17
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Andrew Brennan.
Investment Thesis & Strategy
Andrew Brennan, as an investment analyst at Accolade Partners, invests in various stages of healthcare, health & hospital services, and health IT companies, likely seeking innovative solutions and strong growth potential within the healthcare sector.
Investment Activity
Deals per year over the last 13 years
1
20070
20080
20091
20100
20110
20120
20130
20141
20151
20160
20171
20181
2019Portfolio Companies
Selected investments from their portfolio of 17 companies
R
Richardson
Other · Seed, 0
P
Pure Health Solutions
Healthcare · Seed, 0
T
TASI
Other · Seed, 0
B
Bocchi Laboratories
Biotech · Seed, 0
S
SCS Refrigerated Services
Logistics · Seed, 0
I
ICS
Other · Seed, 0
T
Taymax
Other · Seed, 2019
H
Handel’s Homemade Ice Cream
Food & Beverage · Seed, 2018
W
Walker Advertising
Media/Content · Seed, 2016
T
The Outsource Group
Enterprise · Seed, 2015
K
Katzkin
Consumer · Seed, 2010
C
Communispace
Marketplaces · Seed, 2007
Frequently Asked Questions
Andrew Brennan focuses on Seed stage investments.
Related Investors
Revolution
Washington, United States · 223 deals
International Finance Corporation
Washington, United States · 222 deals
US Department of Commerce, Economic Development Administation
Washington, United States · 132 deals
Paladin Capital Group
Washington, United States · 123 deals
Core Capital Partners
Washington, United States · 87 deals
Updata Partners
Washington, United States · 74 deals